Opinion: Cure ‘futures’ offer a way to pay for million-dollar medicines

Effective new drugs can make the world a better place — unless they aren’t accessible because those making the breakthroughs charge an enormous price to get a decent profit because they can, or because their investors demand it.

People who create viable businesses and their investors have a right to earn a return on the resources they expend to solve a problem, including finding cures for previously incurable diseases. But that is turning out to be problematic when it comes to new medicines, especially those with million-dollar price tags.

A recent focused on a newly approved leukemia treatment with a high success rate. The total treatment cost

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
This Troubled Biotech Needed Cash, So It Turned To A Predatory Lender: Its Own CEO
I don’t write about Northwest Biotherapeutics much anymore because it’s not cool to punch down. However, there was a juicy nugget in the cancer biotech’s recently filed 10-Q that had to be shared. It’s another example of a biotech executive getting r
STAT7 min readPolitics
Trump Has Made A Priority Of Trying To Lower Drug Prices. But Many Of His Most Ardent Supporters Don’t Know It
Few of his supporters — even those willing to blast "Big Pharma" or whose ears perked up at the mention of drug importation — had any idea that Trump had…
STAT4 min readScience
Opinion: Gene Editing To Stop Lyme Disease: Caution Is Warranted
I'm inherently cautious about genetically engineering wild species. but in some cases, it may be relatively safe, beneficial to human health, and worth the presumed risks.